Chester County News and Community Website
NEWTOWN, PA — Helius Medical Technologies, Inc. (NASDAQ: HSDT) announced encouraging results from its PoNSTEP study, presented at the 2025 Consortium of Multiple Sclerosis Centers (CMSC) Annual Meeting. The findings …
Helius Shares Positive PoNSTEP Study Results on PoNS Therapy for MS Read More NEWTOWN, PA — Helius Medical Technologies, Inc. (Nasdaq: HSDT) announced that Aetna Healthcare has authorized a claim for reimbursement for its Portable Neuromodulation Stimulator (PoNS) Device, marking a significant milestone …
Helius Medical Secures Aetna Approval for PoNS Device Reimbursement Read More NEWTOWN, PA — Helius Medical Technologies, Inc. (Nasdaq: HSDT) announced that on June 3, 2025, it received notice from the Nasdaq Hearings Panel confirming compliance with the minimum bid price …
Helius Medical Secures Nasdaq Bid Price Compliance, Eyes Equity Requirement Deadline Read More NEWTOWN, PA — Helius Medical Technologies, Inc. (NASDAQ: HSDT) will reveal groundbreaking findings from its PoNSTEP study at the 2025 Consortium of Multiple Sclerosis Centers (CMSC) Annual Meeting, taking place …
Helius Medical Technologies to Present Breakthrough PoNS Study Results at CMSC Annual Meeting Read More NEWTOWN, PA — Helius Medical Technologies, Inc. (Nasdaq: HSDT) has announced that United Healthcare, one of the largest healthcare providers in the United States, has approved reimbursement for the company’s …
Helius Medical Technologies Secures Key Reimbursement Approval for PoNS Device Read More NEWTOWN, PA — Helius Medical Technologies, Inc. (Nasdaq: HSDT) has announced the creation of Revelation Neuro, Inc., a wholly owned private subsidiary dedicated to developing non-implantable AI-powered brain-computer interface (BCI) technology. …
Helius Medical Unveils Revelation Neuro to Pioneer AI-Powered Neurorehabilitation Read More NEWTOWN, PA — Helius Medical Technologies, Inc. (Nasdaq: HSDT) has achieved a major milestone with its first reimbursement payment from Anthem Blue Cross Blue Shield for its innovative PoNS Device. This …
Helius Medical Secures First Insurance Reimbursement for PoNS Device Read More NEWTOWN, PA — Helius Medical Technologies, Inc. (Nasdaq: HSDT) has announced promising results from its PoNS Therapeutic Experience Program (PoNSTEP), demonstrating the effectiveness of its PoNS Therapy in improving gait deficits …
PoNSTEP Study Confirms Long-Term Benefits of PoNS Therapy for MS Patients Read More NEWTOWN, PA — Helius Medical Technologies, Inc. (Nasdaq: HSDT) announced it has exceeded its initial enrollment target for the stroke registrational program evaluating its Portable Neuromodulation Stimulator (PoNS®). With 128 …
Helius Medical Surpasses Enrollment Target for Stroke Program Read More NEWTOWN, PA — Helius Medical Technologies, Inc. has announced the inaugural sale of its PoNS System to the U.S. Department of Veterans Affairs (VA) Healthcare System. The system, sold through …
Helius Medical Achieves Key Milestone with First PoNS System Sale to VA Read More